Congo Receives Ebola Vaccine Doses Amid Unprecedented Outbreak

The Democratic Republic of Congo is receiving more than 16,000 doses of the Ervebo Ebola vaccine amid its fastest-ever outbreak, according to the health minister. The 16,250 doses arrived at Kinshasa's N’djili International Airport on Friday night, with more expected next week as part of a 70,000-dose shipment announced by the World Health Organization and its partners.

The current outbreak is caused by the rare Bundibugyo virus, for which no approved treatment or vaccine currently exists. The virus can spread easily and its symptoms, similar to malaria, can cause it to go unnoticed. The Ervebo vaccine, though authorized for other Ebola strains, may offer some protection against the Bundibugyo virus.

With 5,375 confirmed cases and 2,557 deaths across six provinces, this outbreak is spreading at an unprecedented rate and is on track to surpass the 2014-2016 West Africa epidemic that killed over 11,000 people. Data indicates transmission has not yet peaked and could triple its current rate.

Containment efforts are severely challenged by ongoing armed conflict in key outbreak areas, attacks on medical personnel and facilities, a mobile population, and displacement due to conflict. These factors, combined with a lack of critical infrastructure, create a difficult environment for controlling the epidemic.